WEE1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: The latest studies report that panobinostat can synergistically enhance the antitumor effect of the selective Wee1 kinase inhibitor MK-1775 or CAR-T cell therapy in PACA (Wang et al., 2015; Ali et al., 2021).